Cargando…

Review of Topical Sodium Heparin 1000 IU/g Gel in Symptomatic Uncomplicated Superficial Thrombophlebitis

Heparin, a mixture of sulfated polymorphic polysaccharides (glycosaminoglycan) chains of variable lengths and weights and a natural anticoagulant, is widely used in medical practice to prevent intravascular blood coagulation. Heparin has demonstrated antithrombotic and anti-inflammatory activity, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabré, Francesc, Camacho, Jairo A, Rodríguez-Garcés, Carlos A, Breier, Débora V, Ballarin, Martín
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658445/ https://www.ncbi.nlm.nih.gov/pubmed/38022089 http://dx.doi.org/10.7759/cureus.47418

Ejemplares similares

A prospective randomized study to evaluate safety and efficacy of heparin topical solution (1000 IU/ml) compared to heparin topical gel (200 IU/g) in prevention of infusion-associated phlebitis
por: Saini, Vikas, et al.
Publicado: (2018)

Vitamin D(3) Supplementation: Comparison of 1000 IU and 2000 IU Dose in Healthy Individuals
por: Dědečková, Eva, et al.
Publicado: (2023)

Postoperative Acute Superficial Thrombophlebitis, an interesting case
por: Sarkar, Soumya, et al.
Publicado: (2021)

Thrombophlebitis of pinna a rare condition: Role of heparin spray
por: Kumar, Neeraj, et al.
Publicado: (2016)

Superficial thrombophlebitis (Mondor's Disease) after breast augmentation surgery
por: Viana, Giovanni André P., et al.
Publicado: (2008)

Experimental Study of Phlebitis Ointment Administration in Acute Superficial Thrombophlebitis
por: Li, Guangzong, et al.
Publicado: (2018)

Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination
por: Aran, Shima, et al.
Publicado: (2022)

Superficial Thrombophlebitis of the Breast (Mondor’s Disease): An Uncommon Localization of Common Disease
por: Obradovic, Katarina, et al.
Publicado: (2020)

Superficial Penile Vein Thrombophlebitis After Microsurgical Varicocelectomy: Case Series
por: Wald, Moshe, et al.
Publicado: (2021)

Cannula provoked upper extremity superficial vein thrombophlebitis: are we overtreating?
por: Yuen, Hiu L. A., et al.
Publicado: (2022)

Epidemiology and outcomes of marked elevations of alanine aminotransferase >1000 IU/L in an Australian cohort
por: Con, Danny, et al.
Publicado: (2019)

Bilateral Lower limbs Superficial Thrombophlebitis in young patients with COVID-19 infection
por: Kumbhalkar, Sunita, et al.
Publicado: (2022)

Coexistence of Superficial Thrombophlebitis and Cutaneous Venulitis in Behçet's Disease: Report of 5 Cases
por: Sato, Mayu, et al.
Publicado: (2022)

Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L
por: Liu, Rujiao, et al.
Publicado: (2016)

A case of COVID‐19 with superficial thrombophlebitis caused by an indwelling peripheral venous catheter
por: Tachi, Hiroaki, et al.
Publicado: (2021)

Comparison of Heparin Quick Penetrating Solution and Diclofenac Quick Penetrating Solution for the Prevention of Superficial Thrombophlebitis Caused by Peripheral Venous Cannulation: A Randomized Double-Blind Study
por: Akhileshwar,, et al.
Publicado: (2019)

Thrombophlebitis Migrans
por: Chatterjee, S. C.
Publicado: (1936)

Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding
por: Hughes, Steven D, et al.
Publicado: (2009)

Variability in the Management of Superficial Venous Thrombophlebitis across Practitioners Based in North America and the Global Community
por: Dua, Anahita, et al.
Publicado: (2014)

Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial
por: Sabico, Shaun, et al.
Publicado: (2021)

300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
por: Persu, Cristian
Publicado: (2014)

Meralgia Paræsthetica and Thrombophlebitis
por: Knox, Edward W.
Publicado: (1963)

Thrombophlebitis of the Cavernous Sinus
por: Hajra, B. B., et al.
Publicado: (1941)

HCV Viral Load Greater Than 1000 IU/ml at Time of Virologic Failure in Direct-Acting Antiviral-Treated Patients
por: Morgan, Jake R., et al.
Publicado: (2021)

Deep Thrombophlebitis of the Lower Limbs
por: Knox, E. W.
Publicado: (1964)

Aortic Aneurysm Simulating Thrombophlebitis
Publicado: (1934)

Multifocal Thrombophlebitis and Orbital Cellulitis
por: Hočevar, Alojzija, et al.
Publicado: (2020)

Bilateral Necrotizing Polymicrobial Thrombophlebitis
por: Jud, Philipp, et al.
Publicado: (2022)

Biofilm-associated candidal thrombophlebitis
por: Fukushima, Shinnosuke, et al.
Publicado: (2023)

Low-level laser therapy for the treatment of superficial thrombophlebitis after chemotherapy in breast cancer patients: a case study
por: Hwang, Woon Taek, et al.
Publicado: (2015)

Cardiac Murmurs Iu Chorea
Publicado: (1871)

Superficial Thrombophlebitis of the Penis following AstraZeneca ChAdOx1-S Vaccination: A Rare Venous Thromboembolic Complication
por: Winston, Joshua, et al.
Publicado: (2022)

No effect of monthly supplementation with 12000 IU, 24000 IU or 48000 IU vitamin D3 for one year on muscle function: The vitamin D in older people study
por: Ranathunga, R.M.T.K., et al.
Publicado: (2019)

Septic Pelvic Thrombophlebitis: Diagnosis and Management
por: Garcia, Javier, et al.
Publicado: (2006)

Migratory Thrombophlebitis and Acute Q Fever
por: Guerrero, Manuel L. Fernandez, et al.
Publicado: (2004)

Challenging presentations of cavernous sinus thrombophlebitis
por: Kraus, Courtney L., et al.
Publicado: (2011)

Cavernous sinus thrombophlebitis complicating sinusitis
por: Berdai, Adnane Mohamed, et al.
Publicado: (2013)

Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy
por: Zhao, Yang-Chao, et al.
Publicado: (2022)

IU professor contributes to particle accelerator
Publicado: (2008)

Activity and toxicity of intramuscular 1000 iu/m(2) polyethylene glycol‐E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials
por: Sidhu, Jasmeet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_68njrn9pci85l1vdlqto93if15